ORAGENICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
ORAGENICS, INC. (OGEN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $14.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-16
- ORAGENICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $14.00K.
- ORAGENICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $70.83K, a 75.55% decline from fiscal 2021.
- ORAGENICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $289.63K, a 34.40% increase from fiscal 2020.
- ORAGENICS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was $215.50K, a 216.15% increase from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $14.00K 10-K · filed 2026-03-16 |
| 2022-12-31 | $70.83K 10-K · filed 2023-04-17 |
| 2021-12-31 | $289.63K 10-K · filed 2023-04-17 |
| 2020-12-31 | $215.50K 10-K/A · filed 2022-07-29 |
| 2019-12-31 | $68.16K 10-K · filed 2021-03-01 |
| 2018-12-31 | -$101.14K 10-K · filed 2020-03-04 |
| 2016-12-31 | -$134.22K 10-K · filed 2018-02-16 |
| 2015-12-31 | -$152.56K 10-K · filed 2017-02-27 |
| 2014-12-31 | $15.21K 10-K · filed 2016-03-30 |
| 2013-12-31 | $118.64K 10-K · filed 2015-02-27 |
| 2012-12-31 | -$8.92K 10-K · filed 2014-02-28 |
| 2011-12-31 | $112.26K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |